Showing results (821-830 of 928) with videos related to
Sort By:
Pageof 93
Lancet (London, England)|November 7, 2021
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trialBo Xu, Shengxian Tu, Lei Song, et al.The Annals of Thoracic Surgery|October 7, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsRebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.The American Journal of Cardiology|March 4, 2014
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry)Gill Louise Buchanan, Alaide Chieffo, Emanuele Meliga, et al.Journal of the American College of Cardiology|October 31, 2024
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal TrialSuzanne V Arnold, Rebecca T Hahn, Vinod H Thourani, et al.JACC. Cardiovascular Interventions|January 6, 2018
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES InitiativeJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.Circulation. Cardiovascular Interventions|July 18, 2020
Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and RegistryErwan Salaun, Marie-Annick Clavel, Rebecca T Hahn, et al.JACC. Cardiovascular Interventions|January 15, 2016
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled TrialsUsman Baber, Gennaro Giustino, Samantha Sartori, et al.The Annals of Thoracic Surgery|August 6, 2015
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I TrialVinod H Thourani, Hanna A Jensen, Vasilis Babaliaros, et al.The American Journal of Cardiology|July 16, 2015
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsGennaro Giustino, Usman Baber, Giulio Giuseppe Stefanini, et al.JACC. Cardiovascular Interventions|September 24, 2016
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Ioannis Mastoris, Usman Baber, et al.Pageof 93